Literature DB >> 19542020

Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study.

John A Heit1, Cynthia L Leibson, Aneel A Ashrani, Tanya M Petterson, Kent R Bailey, L Joseph Melton.   

Abstract

OBJECTIVE: Although diabetes mellitus is reported as a risk factor for venous thromboembolism (VTE), persons with diabetes are frequently hospitalized for medical illness or surgery, or confined to a nursing home, all major VTE risk factors. Consequently, we tested diabetes for an independent association with incident VTE. METHODS AND
RESULTS: Using Rochester Epidemiology Project resources, we identified all Olmsted County, Minn residents who met objective criteria for incident VTE over the 25-year period, 1976 to 2000 (n=1922), and 1 to 2 resident controls per case, matched on age, gender, and length of medical history (n=2115). Complete medical histories in the community were reviewed for previously identified independent VTE risk factors and diabetes-related variables. We tested diabetes and diabetes complications (retinopathy, nephropathy or neuropathy, and ketoacidosis) as potential VTE risk factors, both alone and after adjusting for VTE risk factors. Univariately, diabetes by clinical diagnosis or by stricter criteria (fasting ambulatory blood glucose >/=140 mg/dL or antidiabetic drug therapy), and diabetes complications, were associated with overall incident VTE. However, after controlling for hospitalization for major surgery or medical illness and nursing home confinement, diabetes was no longer associated with VTE.
CONCLUSIONS: Diabetes mellitus and diabetes complications are not independent risk factors for incident VTE.

Entities:  

Mesh:

Year:  2009        PMID: 19542020      PMCID: PMC2735343          DOI: 10.1161/ATVBAHA.109.189290

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  27 in total

Review 1.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

Authors:  Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

2.  Metabolic syndrome as a risk factor for deep vein thrombosis after acute cardiac conditions.

Authors:  Marco Ambrosetti; Walter Ageno; Mario Salerno; Roberto F E Pedretti; Jorge A Salerno-Uriarte
Journal:  Thromb Res       Date:  2007-05-23       Impact factor: 3.944

3.  Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.

Authors:  Robert J Glynn; Bernard Rosner
Journal:  Am J Epidemiol       Date:  2005-10-05       Impact factor: 4.897

4.  The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus.

Authors:  Mohammad-Reza Movahed; Mehrtash Hashemzadeh; M Mazen Jamal
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

5.  The risk of venous thromboembolism is markedly elevated in patients with diabetes.

Authors:  V Petrauskiene; M Falk; I Waernbaum; M Norberg; J W Eriksson
Journal:  Diabetologia       Date:  2005-03-19       Impact factor: 10.122

6.  High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses.

Authors:  C R Keenan; S Murin; R H White
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

7.  Venous thromboembolism--a manifestation of the metabolic syndrome.

Authors:  Cihan Ay; Theres Tengler; Rainer Vormittag; Ralph Simanek; Wolfgang Dorda; Thomas Vukovich; Ingrid Pabinger
Journal:  Haematologica       Date:  2007-03       Impact factor: 9.941

8.  The metabolic syndrome and the risk of venous thrombosis: a case-control study.

Authors:  W Ageno; P Prandoni; E Romualdi; A Ghirarduzzi; F Dentali; R Pesavento; M Crowther; A Venco
Journal:  J Thromb Haemost       Date:  2006-07-17       Impact factor: 5.824

9.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.

Authors:  M D Silverstein; J A Heit; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  1998-03-23

10.  Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

Authors:  Walter Ageno; Cecilia Becattini; Timothy Brighton; Rita Selby; Pieter W Kamphuisen
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

View more
  48 in total

Review 1.  Acute pulmonary embolism. Part 1: epidemiology and diagnosis.

Authors:  Renée A Douma; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-07-20       Impact factor: 32.419

2.  Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay.

Authors:  Armando Tripodi; Adriana Branchi; Veena Chantarangkul; Marigrazia Clerici; Giuliana Merati; Andrea Artoni; Pier Mannuccio Mannucci
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

3.  Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study.

Authors:  David A Froehling; Paul R Daniels; Karen F Mauck; Maria L Collazo-Clavell; Aneel A Ashrani; Michael G Sarr; Tanya M Petterson; John A Heit
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

4.  Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.

Authors:  Aneel A Ashrani; Rachel E Gullerud; Tanya M Petterson; Randolph S Marks; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2016-01-05       Impact factor: 3.944

5.  Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments.

Authors:  Cynthia L Leibson; Tanya M Petterson; Carin Y Smith; Kent R Bailey; Jane A Emerson; Aneel A Ashrani; Paul Y Takahashi; John A Heit
Journal:  Chest       Date:  2014-08       Impact factor: 9.410

6.  Reasons for the persistent incidence of venous thromboembolism.

Authors:  John A Heit; Aneel Ashrani; Daniel J Crusan; Robert D McBane; Tanya M Petterson; Kent R Bailey
Journal:  Thromb Haemost       Date:  2016-12-15       Impact factor: 5.249

Review 7.  Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment.

Authors:  Francisco J Pasquel; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2014-11       Impact factor: 19.112

Review 8.  Role of direct oral anticoagulants in patients with kidney disease.

Authors:  Vimal K Derebail; Michelle N Rheault; Bryce A Kerlin
Journal:  Kidney Int       Date:  2019-12-24       Impact factor: 10.612

Review 9.  Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis.

Authors:  Elizabeth J Bell; Aaron R Folsom; Pamela L Lutsey; Elizabeth Selvin; Neil A Zakai; Mary Cushman; Alvaro Alonso
Journal:  Diabetes Res Clin Pract       Date:  2015-11-10       Impact factor: 5.602

10.  Venous thromboembolism in nursing home residents: role of selected risk factors.

Authors:  Cynthia L Leibson; Tanya M Petterson; Carin Y Smith; Kent R Bailey; Aneel A Ashrani; John A Heit
Journal:  J Am Geriatr Soc       Date:  2012-08-06       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.